VIB presents its annual results at BIO2004 in San...( San Francisco BIO2004; The North Ameri...)

San Francisco, BIO2004; The North American biotech convention 'BIO' has blossomed into the place to be. Every year, the international biotech community gathers together at this mega-happening, which this year boasts 20,000 participants. VIB (the Flanders Interuniversity Institute for Biotechnology) is coordinating the Belgian delegation to 'BIO 2004' in San Francisco, where it will present its newly published annual results. These latest results from 2003 - with the large number of major research breakthroughs, 30 patent applications, and almost 50 agreements with industry - clearly position VIB among the top in the world.

In 2003, VIB scientists achieved 180 significant breakthroughs in a variety of domains such as cancer, Alzheimer's disease, inflammatory diseases, human genetics, and plant growth. This figure surpasses that of the previous year, which was already three times as many as at the start of the institute in 1995. This result vaults Flanders' biotechnological research to the top internationally. Also in 2003, VIB expanded its research groups with 3 new ones active in emerging fields in the life sciences. In fact, this is an instance of reverse brain drain, because, after an international search, 3 Belgians proved to be the best candidates and they were eager to return to Flanders after successful careers abroad.

VIB's innovative knowledge is a continuous source of new technologies and inventions that can form the basis for new social and industrial applications, including medical diagnostics and medicines. To bring these applications into being, VIB protects its findings via patents: in 2003, 30 discoveries were sufficiently new and inventive to warrant patent applications. At the same time, VIB entered into nearly 50 collaborative agreements with business and industry. In addition, VIB was the catalyst for the creation of a new network - called 'FlandersBio' - that unites the Flemish biotech industry.

'"/>

Contact: Ann Van Gysel
inge.geysen@vib.be
32-475-336-600
VIB, Flanders Interuniversity Institute of Biotechnology
3-Jun-2004

Page: 1
Related biology news :

1. DFG presents the 2004 MAK and BAT value lists
2. Steroid-coated DNA represents new approach to gene delivery
3. ASH presents advocacy awards to Sen. Dianne Feinstein and Claude Lenfant, M.D.
4. DFG presents the new MAK and BAT Value List 2003
5. Center for Health Law and Policy presents program on bioterrorism measures and civil liberties
6. Agriculture presents common ground for rural, urban people
7. UPCI presents study on estrogenic activity of medicinal botanicals
8. UPCI presents study on dendritic cells in prostate cancer
9. UPCI presents study on discovery of protein that suppresses dendritic cells
10. USF presents new research on hyperlipidemic children
11. Biomedicines presents promising results from phase II trials of omega interferon for the treatment of hepatitis C